A trial looking at anastrozole to prevent breast cancer in postmenopausal women (IBIS II Prevention)

Overview

Cancer types:

Breast cancer

Status:

Results

Phase:

Phase 3

Details

This trial looked at whether a drug called anastrozole could reduce the risk of breast cancer in post menopausal women who are at a high risk of getting the disease.

Cancer Research UK supported this trial.

Recruitment start: 2 February 2003

Recruitment end: 31 January 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Jack Cuzick

Professor John Forbes

Professor Anthony Howell

Supported by

AstraZeneca

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Queen Mary University of London

Sanofi Aventis

Other information

This is Cancer Research UK trial number CRUK/04/032/033.

Last reviewed: 19 December 2019

CRUK internal database number: 228

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.